Condition
Meningioma Atypical
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown2
Recruiting2
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT04792463Recruiting
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
NCT05793034Not ApplicableRecruiting
Predictive Factors for Survival in Aggressive Meningiomas
NCT05259332UnknownPrimary
Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical Meningiomas
NCT05081908Not ApplicableUnknownPrimary
Multisession Radiosurgery in Residual/Recurrent Grade II Meningiomas.
NCT04127760Not ApplicableNot Yet RecruitingPrimary
Efficacy of Postoperative Radiotherapy for Atypical Meningioma Without Venous Sinus Invasion After Gross-total Resection
Showing all 5 trials